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A totally abiotic ELISA-like assay, where no elements of biological origin are used, either for 
molecular recognition or for reporting purposes, is presented here. Using a novel synthetic 
approach, with immobilized template, surface-imprinted nanoparticles were prepared with a 
catalytic core capable of promoting a colorimetric reaction; these were used for combined 
target recognition and reporting. In microplate-competitive format the assay was capable of 
selectively determining vancomycin concentration from 10 nM to 1 mM, and with minimal 
modifications to standard assay protocols.  Results point towards the future development of a 
new generation of assays based entirely on stable and potentially more affordable synthetic 
reagents. 
 Immunoassays have long been used in clinical, food, environmental and forensic industries to 
monitor a wide range of targets, ranging from proteins to DNA sequences and drugs.[1, 2] Of 
these, the enzyme-linked immuno-sorbent assay (ELISA) is probably the most common 
method, based on the competition between free and enzyme-labeled ligand to bind to 
immobilized targets or antibodies.[3] Although rapid, sensitive and cost effective for large 
sample loads, immunoassays have several disadvantages, mostly connected with limited 
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stability/batch variability and the expense of production and use of antibodies and reporter 
enzymes.  
Molecularly Imprinted Nanoparticles (MIN) capable of recognition of a target molecule have 
been identified as promising alternatives to antibodies in a range of applications[4-6]. However, 
the added advantages (mainly storage/thermal stability and low cost) conferred by the use of 
imprinted materials as antibody replacements might not be effectively exploited if the assay 
system still requires the presence of a biological reporter enzyme. Accordingly, here we report 
the integration of catalytically active Fe3O4 with MIN as combined recognition and signaling 
functionalities in a core-shell nanoparticle format suitable for use in ELISA-like assays. The 
intrinsic peroxidase mimicking activity of γFe3O4 nanoparticles has been recently identified,[7] 
making them attractive substitutes for the enzyme in a variety of assays, with stable catalytic 
activity over a broad range of temperatures, low cost/long shelf life and ease of manufacture. 
In order to produce the composite core-shell Fe3O4-MIN, a variation of the solid-phase 
imprinting protocol[8] was used, Scheme 1. This method was devised taking into 
consideration its potential for scale-up and automation, both important factors to consider 
regarding potential practical applications of the technology. That synthesis and purification 
time < 1 h per batch of particles is also advantageous. Briefly, the protocol consisted of the 
addition of monomer mixture and UV initiator, containing a dispersion of 3-(trimethoxysilyl) 
propyl methacrylate modified γFe3O4 nanoparticles (d ≤ 50 nm), to the solid phase (glass 
beads) bearing the immobilized target template (vancomycin). After a short period of UV 
irradiation (2.5 min), nanoparticles were formed,[9][8] and the solid phase containing the 
template and the bound MINs then functioned as an affinity support for the 
fractionation/purification of high-affinity MINs from the remaining polymer/unreacted 
monomers (see S. I. for full details), by washing with solvent at room temperature. High 
affinity materials were collected by elution at 60 °C. Subsequent magnetic separation of the 
high-affinity particles ensured that only those containing the magnetic Fe3O4 core were 
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recovered. Consequently the collected MINs possessed both high-affinity (affinity separation 
step on the solid phase) and a Fe3O4 core (magnetic separation). Control (non-imprinted) 
particles were prepared in absence of immobilized template.  Fe3O4-MINs had diameters of 
113 ± 23 nm and Fe3O4-C (control) particles 81 ± 2 nm (by DLS). Particles possessed a core-
shell structure, with a polymer shell surrounding the Fe3O4 core, Scheme 1. To increase 
polymer contrast during imaging, particles were stained with OsO4.  A TEM image of the core 
Fe3O4 is presented as S. I (Figure S1) confirming particles have a diameter below 50 nm. To 
demonstrate that specific interactions between polymer and template were responsible for 
retention of the particles by the solid phase (during the cold column washing), control 
experiments were performed by loading the polymerisation mixture containing Fe3O4 
nanoparticles onto the solid phase. In the absence of a polymerization step, 99.59 % of the 
Fe3O4 was eluted during the cold wash. Following a polymerization step, only 82.75 % is 
eluted cold, with 17.25 % recovered during the hot wash (high affinity fraction) and included 
in the core-shell MINs. When the surface of the Fe3O4 core was not modified with 
methacrylate groups, a decrease in yield was observed (15.95 % recovered during hot wash) 
so modified Fe3O4 nanoparticles ware used on subsequent experiments.   The composition of 
the polymerization mixture was based on a published protocol[8, 10] and included N-
isopropylacrylamide, N-tert-butyl acrylamide, acrylic acid and the cross-linker N, N’-
methylenebis(acrylamide). The full composition is given in S. I. Target recognition with this 
type of polymer can be attributed[4] to a combination of multiple weak electrostatic and 
hydrophobic interactions and is especially suited to the imprinting of large molecules.  
The kinetics of the catalytic oxidation of TMB by Fe3O4 nanoparticles were studied by 
measuring the absorbance of the solution at 650 nm in 300 sec intervals, and compared for 
both free Fe3O4 and Fe3O4-MIN nanoparticles.   Michaelis-Menten kinetics parameters (vmax 
and Km) were calculated using the Lineweaver–Burk double reciprocal plot (see S. I, Figure 
S2). The catalytic constant (kcat) was calculated according to Equation (1):   
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kcat = vmax/[E]                                                                                                  (1) 
 
where [E] is the Fe3O4 concentration (2.15 × 10-10 M). Catalytic parameters are summarized 
on Table 1. Results indicate that presence of the polymer shell does not significantly interfere 
with the catalytic activity of the nanoparticles. This can be attributed to the fact that the 
hydrophilic porous polymer shell, with low percentage of cross-linker (2%) is swollen in 
aqueous media, and so causes little resistance to the diffusion of the small-molecule reactants. 
Also, this is in accordance with Woo[11] who observed small increases in Vmax values for 
Fe3O4 nanoparticles after surface derivatization/coating with proteins.  
Although imprinted polymers have the potential to directly replace natural receptors in assays 
such as ELISA, the materials produced using classical protocols have generally proved 
unsuitable for such applications due to a number of factors. Firstly, traditional MIPs are 
highly “polyclonal“ in relation to their binding behavior (i.e. binding sites distributed 
throughout the polymer bulk and surface which have a wide range of affinities towards the 
target molecule) and suffer from high levels of non-specific binding. Secondly, the protocols 
for integration of imprinted polymers with assays are complicated and non-generic, requiring 
significant modifications to the procedure used for their manufacture or performance of the 
assay. Aiming to solve some of these problems we have developed the solid-phase imprinting 
method for synthesis of MINs with pseudo-monoclonal properties.[8] As detailed in Scheme 1, 
by combining the affinity separation (for removal of low-affinity MINs) and the fact that 
particles have a limited number of binding sites (only at the point of contact with the solid-
phase), the final product will have more uniform binding characteristics resembling those of 
monoclonal antibodies when compared with imprinted polymers prepared using traditional 
methods with free template in solution. MIN as produced here can be employed as direct 
replacements of antibodies/enzyme in standard ELISA-like assays with minimal 
modifications to the protocol. To demonstrate this, we selected the glycopeptide antibiotic 
vancomycin as analyte which  also can point the way to the use of synthetic peptide epitopes 
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instead of whole proteins in this type/format of assay,[12] again, to avoid using potentially 
unstable or expensive biomaterials. To develop the MIN-based assay, vancomycin was 
initially conjugated onto the well surface of a 96 well micro plate (via amine coupling, 
polystyrene plate surface derivatized with maleic anhydride). Then, in order to assess if 
imprinted nanoparticles cold bind preferentially to this surface, as opposed to surfaces without 
derivatization, particles were loaded onto the wells which were subsequently washed. 
Random/irreproducible peroxidase activity values were detected on wells without 
immobilized vancomycin, ranging from no activity to values similar to those of Fe3O4-C on 
vancomycin-derivatized surface (see text below).  High peroxidase activity was only detected 
on surfaces containing immobilized vancomycin and attached nanoparticles were then 
visualized by Atomic Force Microscopy (AFM), Figure 1. The incomplete coverage of the 
surface with particles might indicate that the performance of the assay can be improved by 
optimization of the surface characteristics. This can be related with incomplete surface 
coverage with reactive groups, or some of these are too close to the surface to allow for MIN 
binding. The use of spacer groups between target molecule and surface, or the use of different 
coupling techniques will be investigated in the future order to improve the amount of 
nanoparticles which can be bound to the surface, and so increase the amount of catalytic sites, 
with consequent increases in measured absorbances. The peroxidase activity was determined 
by addition of standard colorimetric substrate 3,3′,5,5′-tetramethylbenzidine (TMB) for 
ELISA and hydrogen peroxide. TMB produces a blue color when oxidized by hydroxyl 
radicals produced in the presence of a catalyst (such as Fe3O4 or peroxidases) and H2O2.[7]  By 
measuring the rate of color development in the reaction system with TMB, H2O2 and Fe3O4-
MINs at different concentrations it was found that the quantity of nanoparticles remaining in 
the wells after incubation and washing (in the absence of free vancomycin) is equivalent to ca. 
20 μg mL-1. The MIN-based assay was then performed in competitive mode. Upon addition of 
MINs and vancomycin solutions, the extent of nanoparticles bound to the well surface was 
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found to be dependent on the amount of free vancomycin in solution (by measuring the 
peroxidase activity) after incubation and washing to remove unbound MINs. A good 
correlation was observed between the absorbance of the solution and the concentration of 
vancomycin over the range from 10 nM to 1 mM (Figure 2). When control Fe3O4-C particles 
were used, in the absence of free vancomycin, a response of 89 ± 11 mAU was recorded, as 
compared to 834 ± 47 mAU for the Fe3O4-MINs (both values obtained after 1 hour incubation 
with 100 µL nanoparticle solution, 50 µg/mL, loaded in each well and following washing). 
The absorbance values obtained with Fe3O4-C were not affected by the presence of 
vancomycin.  While vancomycin was selected primarily as a model analyte, the obtained 
linear range is well within the recommended serum monitoring levels of 7 to 14 µM,[13, 14] 
demonstrating potential for the development of vancomycin assays based on this methodology. 
The assay was found to be specific, with minimal response to other antibiotics, each present at 
0.1 µM Figure 1 (inset). While there is no vancomycin analogue available, bleomycin and 
gentamycin share chemical similarities with vancomycin, hence their selection. Whilst this 
demonstration study has been performed in buffer solution, and could possibly be translated 
with minor modifications for quantification of a wide range of analytes in relatively simple 
matrixes (such as urine or environmental samples), analysis in serum/blood will probably 
require optimization work related with type/length of linker between target and plate surface, 
washing/blocking agents and protocols.   In conclusion, we have demonstrated the possibility 
to perform an ELISA-like assay where no biological material was used, either for recognition 
or reporting purposes, with minimal modifications to the standard protocol. Peroxidase-
mimicking imprinted nanoparticles were produced by the solid-phase imprinting method in 
the presence of Fe3O4 and used for combined target recognition and reporting by catalyzing 
the oxidation of TMB. The results are a starting point for the development of a new 
generation of assays using stable synthetic reagents, which could find uses especially in 
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field/emergency conditions or in locations where a cold-chain for storage and transport is 
unavailable. 
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Supporting Information is available online from the Wiley Online Library or from the author. 
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Scheme 1. Representation of the solid-phase synthesis protocol with addition of Fe3O4 for 
preparation of peroxidase-mimicking core-shell MIN (left) and TEM image of the obtained 
Fe3O4-MIN particles (right). 
 
 
 
 
Figure 1. AFM images showing topography of the micro plate well surface before (left) and 
after 1 hour incubation with 100 µL Fe3O4-MINs (50 µg mL-1) and washing (3 × 100 µL) 
with deionized water. 
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Figure2. On the left, scheme of the assay in competitive mode, and on the right, calibration 
curve for vancomycin obtained with core-shell catalytic MIN (main) and (inset) normalized 
assay response (cross-reactivity) to different antibiotics, all experiments performed under 
physiological conditions(PBS 1×, pH 7.2). Solutions of Fe3O4-MINs (100 µL, 50 µg mL-1) 
were added to each of the vancomycin modified wells, followed by 50 µL vancomycin 
solution.  After one hour incubation, wells were washed (3 × 100 µL PBS) and colorimetric 
TMB assay performed, full details in S. I.  Error bars represent ± 1 standard deviation and 
are for experiments performed in triplicate. 
 
Table 1. Table 1. Apparent kinetic parameters of Fe3O4 nanoparticles and Fe3O4-MIN as 
peroxidase mimics.  
Particle 
type 
Km [M] vmax [M s-1] kcat [s-1] (kcat/Km) 
[(M s)-1] 
Fe3O4 0.49 16.8 × 10-9 77.8 156.3 
Fe3O4-MIN 0.48 19.8 × 10-9 92.1 190.6 
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A new ELISA-like assay where no elements of biological origin are used for molecular 
recognition or signaling is demonstrated here. Synthesized using a solid-phase approach, 
composite imprinted nanoparticles containing a catalytic core can simultaneously act as 
recognition/signaling elements, and be used with minimal modifications to standard assay 
protocols. This provides a new route towards replacement of unstable biomolecules in 
immunoassays. 
 
Keyword molecular imprinting, core/shell materials, peroxidase, solid-phase synthesis 
 
Roman V. Shutov, Antonio Guerreiro,* Ewa Moczko, Isabel Perez de Vargas-Sansalvador, 
Iva Chianella, Michael J. Whitcombe, Sergey A. Piletsky 
 
Introducing MINA - The molecularly Imprinted Nanoparticle Assay 
 
ToC figure  
 
 
 
 
 
Copyright WILEY-VCH Verlag GmbH & Co. KGaA, 69469 Weinheim, Germany, 2013. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Submitted to  
   11      11   
 
Supporting Information  
 
for Small, DOI: 10.1002/smll.((please add manuscript number))  
 
Introducing MINA - The molecularly Imprinted Nanoparticle Assay 
 
Roman V. Shutov, Antonio Guerreiro,* Ewa Moczko, Isabel Perez de Vargas-Sansalvador, 
Iva Chianella, Michael J. Whitcombe, Sergey A. Piletsky 
 
 
Experimental procedures 
Materials 
3-(trimethoxysilyl) propyl methacrylate, 3-aminopropyltrimethyloxysilane (APTMS), 
glutaraldehyde (GA), phosphate buffered saline (PBS), N-isopropylacrylamide (NIPAm), 
acrylic acid (AA), N,N’-methylene-bis-acrylamide (BIS), N-tert-butylacrylamide (TBAm), 
vancomycin, gentamycin, bleomycin, amoxicillin, ethanolamine, 3,3′,5,5′-
tetramethylbenzidine (TMB) ready solution for ELISA, hydrogen peroxide (34%), Fe3O4 
nanopowder (particle size ≤ 50 nm), osmium tetroxide  were purchased from Sigma-Aldrich, 
UK. Acetonitrile (ACN) and sodium hydroxide were obtained from Fisher Scientific (UK). 
Diethyldithiocarbamic acid benzyl ester was obtained from TCI Europe (Belgium). RO 
ultrapure water (Millipore) was used throughout. All chemicals and solvents were analytical 
or HPLC grade and were used without further purification. Phosphate buffered saline (PBS) 
was prepared as directed from 1 × PBS buffer tablets (Sigma-Aldrich, UK), pH adjusted to 
7.2, at 25 ° C.  Amine-binding maleic anhydride 96-well micro plates were purchased from 
Pierce (Thermo-Fisher Scientific, USA), and used as directed by the manufacturer. Solid glass 
beads (40 µm ≤ diameter ≤ 106 µm, average diameter 90 µm, were purchased from Blagden, 
UK.   
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Preparation of vancomycin-derivatized glass beads 
The protocol for the immobilization of vancomycin on glass beads has already been described 
elsewhere.[SI1] Briefly, glass beads were activated by boiling them in 1M NaOH for 10 min 
and washed with double-distilled water followed by acetone and then dried. The beads were 
then incubated overnight in a solution of APTMS in toluene (0.4 mL solution/g glass beads), 
washed with acetone and subsequently incubated overnight at 4 °C in a solution of 5 % GA in 
PBS pH 7.2 (0.4 mL solution/g glass beads) then washed with water. The surface 
immobilization of vancomycin was performed by incubating the beads with a solution of 
vancomycin (5 mg mL-1) in PBS, pH 7.2, overnight at 4 °C, again with 0.4 mL solution per g 
glass beads. This method yields ca. 0.26 ligand molecules nm-2 of glass bead surface.[SI 1] 
Finally, the glass beads were washed with double-distilled water, dried under vacuum and 
stored at 4 °C until used. 
 
Preparation of Fe3O4 derivatized with 3-(trimethoxysilyl) propyl methacrylate  
 One gram of Fe3O4 nanopowder was suspended in 45 mL of dry toluene to which 3-
(trimethoxysilyl) propyl methacrylate (5 mL) was added under stirring. The suspension was 
incubated in an ultrasound bath for 4.5 hours. The derivatized Fe3O4 nanopowder was then 
separated from solution using a magnet, washed with five times 45 mL toluene and dried 
under vacuum overnight.  
 
Preparation of Fe3O4-MIN  
The polymerization mixture was prepared by mixing NIPAm (0.936 g) as backbone monomer, 
BIS (0.048 g) as cross-linker, TBAm (0.8 g) as hydrophobic functional monomer, AA (56.8 
μL) as negatively-charged functional monomer and N,N-diethyldithiocarbamic acid benzyl 
ester (0.152 g) as initiator (iniferter) in ACN (7.87 g) (total monomer concentration: 18% 
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w/v) and 0.05 g Fe3O4 nanopowder derivatized with 3-(trimethoxysilyl) propyl methacrylate. 
The mixture was placed in a 20 mL glass vial and purged with N2 for 20 min and sonicated in 
an ultrasound bath during 10 min.  Vancomycin-derivatized glass beads (solid phase, 50 g), 
prepared as described above were placed in a 200 mL flat-bottomed glass beaker fitted with a 
flat glass lid and degassed under vacuum for 20 min, the air inside the beaker then replaced 
with N2. The polymerization mixture was poured onto the solid phase and the vessel then 
placed between two UV light sources (both Philips model HB/171/A, each fitted with 4×15 W 
lamps) for 2.5 min under a nitrogen atmosphere. After polymerization, the contents of the 
beaker were transferred into an SPE cartridge fitted with a polyethylene frit (20 µm porosity) 
in order to perform the temperature-based affinity separation of Fe3O4- MIN. The temperature 
of ACN and the SPE cartridge was kept at 20 °C (same as polymerization step). Washing was 
performed with 8 bed volumes of ACN (relative to the volume of the solid phase, approx. 8 × 
30 mL), using a vacuum manifold. This was done in order to remove non polymerized 
monomers and low affinity polymer. The effectiveness of the washing was verified by 
measuring the UV absorbance of washing aliquots, in order to ensure complete monomer 
removal. Afterwards the SPE cartridge containing the solid-phase with high-affinity Fe3O4-
MIN attached was heated up to 60 °C and eluted with 3×30 mL ACN at 60 °C. The particles 
were then collected at the bottom of the collection vial by a magnet, the supernatant discarded, 
followed by re-suspension of material in 20 mL ACN. This procedure was repeated three 
times. Concentration of Fe3O4-MIN in the final solution was determined by freeze-drying. 
The working solution for the assay was prepared by transferring an aliquot of Fe3O4-MIN 
solution in ACN, followed by magnetic separation and re-suspension in PBS. Two magnetic 
separation/re-suspension cycles were performed; concentration of Fe3O4-MIN was adjusted to 
50 μg/mL for the assay experiments. Molar concentration of Fe3O4 in stable suspensions was 
determined spectrophotometrically. Control non-imprinted particles were prepared in absence 
of template-derivatized solid phase. After polymerization, materials were removed from 
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solution by magnetic separation. The particles were then washed with ACN. For this, six 
cycles of separation/re-suspension with 20 mL ACN/cycle were performed. The working 
solution for the assay was prepared by transferring an aliquot of Fe3O4-MIN solution in ACN, 
followed by magnetic separation and re-suspension in PBS. Two magnetic separation/re-
suspension cycles were performed. 
 
Size analysis of nanoparticles 
Solutions of nanoparticles at 50 μg/mL were sonicated for 5 minutes and then analyzed at 
25 °C using a Zetasizer Nano (Nano-S) from Malvern Instruments Ltd (UK). For transmission 
electron microscope analyses, Fe3O4-MIN samples were stained with osmium tetroxide by 
adding 50 µL of 2 % solution to 1 mL nanoparticles solution in water. Solutions were held for 
4 hours and then vented on a fume hood overnight to remove excess osmium tetroxide. 
Caution! Osmium tetroxide is highly poisonous, even at low exposure levels. After staining, 
particles were placed on a carbon-coated copper grid and dried on air. The microscope used 
was a Philips CM20 transmission electron microscope.   
 
AFM analysis 
The surface of the interior bottom section of a well from the 96 well micro plate was used for 
AFM analysis. The instrument was a Bruker Dimension 3100, and analysis performed in 
tapping mode. 
 
Vancomycin conjugation to the micro plate surface 
Micro plate wells were washed with PBS (3×100 μL) then vancomycin solution was added 
(20 μM, 100 μL, pH 8) and allowed to stand overnight at room temperature. Then the solution 
was poured out and ethanolamine solution (50 mM, 100 μL) in PBS was added as blocking 
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solution and allowed to stand for 1 h. Afterwards wells were washed twice (100 μL) and air-
dried. 
Assay procedure 
To the vancomycin-modified micro plate wells containing nanoparticle suspension (100 μl) 
and vancomycin solution at various concentrations (50 μl) were incubated for 1 h with 
constant shaking. Then the solution was poured out, the wells were washed with PBS (3×100 
μl) and afterwards 100 μL of TMB solution and 50 μL of hydrogen peroxide were added and 
incubated  for 1 h in the dark to develop the color. Then 50 μl of 0,1 M sulfuric acid were 
added and absorbance was measured using UV/Visible micro plate reader (Dynex, UK) at 450 
nm. 
 
Determination of kinetic parameters 
To microplate wells containing nanoparticles solution (final concentration Fe3O4 0.21 nM), 
100 μL of TMB solution and 50 μL of H2O2 were added. H2O2 was added at different 
concentrations in order to obtain the following final concentration of 1.47 M, 0.98 M, 0.73 M, 
0.49 M, 0.49 M, 0.36 M, 0.18 M.  Absorbance was then measured every 300 seconds for 45 
minutes at 650 nm. Absorbance data were back-calculated to concentration using a molar 
absorption coefficient of 39000 M-1cm-1 for TMB-derived oxidation products.[SI2] Michaelis-
Menten kinetics parameters were calculated using the Lineweaver–Burk (double reciprocal) 
plot. 
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Supporting data 
 
 
Figure S1. TEM image of core Fe3O4 nanoparticles. 
 
 
 
 
Figure S2. Lineweaver–Burk plots for catalysis of H2O2 by core Fe3O4 nanoparticles (A) and 
Fe3O4 –MIN nanoparticles (B). 
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